# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-184680
Filing Date
2025-08-21
Accepted
2025-08-21 08:15:30
Documents
37
Period of Report
2025-08-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d57006d8k.htm iXBRL | 8-K | 26521
2 | EX-99.1 | d57006dex991.htm | EX-99.1 | 32956
3 | EX-99.2 | d57006dex992.htm | EX-99.2 | 36538
7 | GRAPHIC | g57006dsp_aa.jpg | GRAPHIC | 2827
8 | GRAPHIC | g57006ex99_2s10g1.jpg | GRAPHIC | 77708
9 | GRAPHIC | g57006ex99_2s11g1.jpg | GRAPHIC | 110834
10 | GRAPHIC | g57006ex99_2s12g1.jpg | GRAPHIC | 88708
11 | GRAPHIC | g57006ex99_2s13g1.jpg | GRAPHIC | 82049
12 | GRAPHIC | g57006ex99_2s14g1.jpg | GRAPHIC | 79412
13 | GRAPHIC | g57006ex99_2s15g1.jpg | GRAPHIC | 76019
14 | GRAPHIC | g57006ex99_2s16g1.jpg | GRAPHIC | 108545
15 | GRAPHIC | g57006ex99_2s17g1.jpg | GRAPHIC | 108448
16 | GRAPHIC | g57006ex99_2s18g1.jpg | GRAPHIC | 89903
17 | GRAPHIC | g57006ex99_2s19g1.jpg | GRAPHIC | 126600
18 | GRAPHIC | g57006ex99_2s1g1.jpg | GRAPHIC | 119961
19 | GRAPHIC | g57006ex99_2s20g1.jpg | GRAPHIC | 109186
20 | GRAPHIC | g57006ex99_2s21g1.jpg | GRAPHIC | 160962
21 | GRAPHIC | g57006ex99_2s22g1.jpg | GRAPHIC | 85891
22 | GRAPHIC | g57006ex99_2s2g1.jpg | GRAPHIC | 196443
23 | GRAPHIC | g57006ex99_2s3g1.jpg | GRAPHIC | 126967
24 | GRAPHIC | g57006ex99_2s4g1.jpg | GRAPHIC | 92186
25 | GRAPHIC | g57006ex99_2s5g1.jpg | GRAPHIC | 116076
26 | GRAPHIC | g57006ex99_2s6g1.jpg | GRAPHIC | 92483
27 | GRAPHIC | g57006ex99_2s7g1.jpg | GRAPHIC | 78712
28 | GRAPHIC | g57006ex99_2s8g1.jpg | GRAPHIC | 89280
29 | GRAPHIC | g57006ex99_2s9g1.jpg | GRAPHIC | 79287
| Complete submission text file | 0001193125-25-184680.txt |  | 3400851

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | dvax-20250821.xsd | EX-101.SCH | 2848
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dvax-20250821_lab.xml | EX-101.LAB | 17992
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dvax-20250821_pre.xml | EX-101.PRE | 11259
40 | EXTRACTED XBRL INSTANCE DOCUMENT | d57006d8k_htm.xml | XML | 3667

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 251238451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)